Renal Cell Carcinoma Whole Blood

<h2>Renal Cell Carcinoma Whole Blood for Research</h2>
Renal cell carcinoma (RCC) is the most common form of kidney cancer, with the clear cell subtype frequently driven by VHL gene loss and studied through angiogenesis and immune checkpoint pathways. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed RCC diagnosis for oncology biomarker research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed RCC donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including RCC subtype and VHL status where available</li><li>Demographics: age, sex assigned at birth, ethnicity</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>VHL gene loss and angiogenesis pathway research</li><li>Immune checkpoint biomarker studies</li><li>Gene expression and transcriptomic analysis</li><li>Tyrosine kinase inhibitor and immunotherapy response research</li></ul>
<h3>Also Available</h3>
Looking for our general kidney cancer product? See our <a href=”https://sanguinebio.com/product/kidney-cancer-whole-blood/”>Kidney Cancer Whole Blood</a> product.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
RCC whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.